Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth H Fischbeck

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
Neurology. Clinical Practice|August 14, 2024
Patient-Reported Impact of Symptoms in Spinal and Bulbar Muscular AtrophyAbdullah Alqahtani, Angela Kokkinis, Christine Zizzi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 11, 2005
Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null miceSteven S Scherer, Yi-Tian Xu, Albee Messing, et al.
Genes & Development|June 20, 2003
Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding proteinJ Paul Taylor, Addis A Taye, Catherine Campbell, et al.
Human Molecular Genetics|March 26, 2003
Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing proteinJ Paul Taylor, Fumiaki Tanaka, Jon Robitschek, et al.
Archives of Neurology|June 15, 2007
Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxiaNicholas A Di Prospero, Charlotte J Sumner, Scott R Penzak, et al.
Scientific Reports|June 18, 2016
The polyglutamine-expanded androgen receptor responsible for spinal and bulbar muscular atrophy inhibits the APC/C(Cdh1) ubiquitin ligase complexLaura C Bott, Florian A Salomons, Dragan Maric, et al.
Annals of Clinical and Translational Neurology|March 22, 2018
Nucleocytoplasmic transport defect in a North American patient with ALS8Robert D Guber, Alice B Schindler, Maher S Budron, et al.
Journal of Rehabilitation Medicine. Clinical Communications|September 8, 2022
SAFETY AND TOLERABILITY OF STRENGTH TRAINING IN SPINAL AND BULBAR MUSCULAR ATROPHY: A CASE REPORTVincent Shieh, Cris Zampieri, Paul Stout, et al.
Human Molecular Genetics|July 17, 2012
Histone deacetylase inhibition suppresses myogenin-dependent atrogene activation in spinal muscular atrophy miceKatherine V Bricceno, Paul J Sampognaro, James P Van Meerbeke, et al.
BMC Neurology|February 3, 2006
A novel cell immunoassay to measure survival of motor neurons protein in blood cellsStephen J Kolb, Amelie K Gubitz, Robert F Olszewski, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Neurology. Clinical Practice|August 14, 2024
Patient-Reported Impact of Symptoms in Spinal and Bulbar Muscular AtrophyAbdullah Alqahtani, Angela Kokkinis, Christine Zizzi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 11, 2005
Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null miceSteven S Scherer, Yi-Tian Xu, Albee Messing, et al.
Genes & Development|June 20, 2003
Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding proteinJ Paul Taylor, Addis A Taye, Catherine Campbell, et al.
Human Molecular Genetics|March 26, 2003
Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing proteinJ Paul Taylor, Fumiaki Tanaka, Jon Robitschek, et al.
Archives of Neurology|June 15, 2007
Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxiaNicholas A Di Prospero, Charlotte J Sumner, Scott R Penzak, et al.
Scientific Reports|June 18, 2016
The polyglutamine-expanded androgen receptor responsible for spinal and bulbar muscular atrophy inhibits the APC/C(Cdh1) ubiquitin ligase complexLaura C Bott, Florian A Salomons, Dragan Maric, et al.
Annals of Clinical and Translational Neurology|March 22, 2018
Nucleocytoplasmic transport defect in a North American patient with ALS8Robert D Guber, Alice B Schindler, Maher S Budron, et al.
Journal of Rehabilitation Medicine. Clinical Communications|September 8, 2022
SAFETY AND TOLERABILITY OF STRENGTH TRAINING IN SPINAL AND BULBAR MUSCULAR ATROPHY: A CASE REPORTVincent Shieh, Cris Zampieri, Paul Stout, et al.
Human Molecular Genetics|July 17, 2012
Histone deacetylase inhibition suppresses myogenin-dependent atrogene activation in spinal muscular atrophy miceKatherine V Bricceno, Paul J Sampognaro, James P Van Meerbeke, et al.
BMC Neurology|February 3, 2006
A novel cell immunoassay to measure survival of motor neurons protein in blood cellsStephen J Kolb, Amelie K Gubitz, Robert F Olszewski, et al.
Pageof 14